Cancer Institute Translational Technology Platforms
The Cancer Institute Translational Technology Platforms (CI TTPs) are underpinned by funding from the CRUK UCL Centre infrastructure grant and the Cancer Institute. As funding for the CI TTPs comes predominantly from the CRUK UCL Centre award, the CRUK UCL Centre is responsible for the overarching governance for all CI TTPs. The TTPs are open to CRUK UCL Centre members to support the Centre’s research programme. Funding for the CI TTPs also comes from the Experimental Cancer Medicine Centre (ECMC), National Institute of Health Research (NIHR) UCL Hospitals Biomedical Research Centre (BRC) and the Medical Research Council (MRC).
If you have any comments or queries regarding the CI TTPs, please contact us at: email@example.com.